Archive for July, 2007

28
Jul

Biology / Biochemistry NewsUseful Links

Researchers find three major beetle groups coming up one testicle short

Main Category: Biology / Biochemistry News
Article Date: 05 Mar 2005 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article   icon newsletters

BERKELEY - A surprisingly large number of beetles are missing one of their testes, the male gonads of insects. As far as the researchers who discovered this can tell, the insects are not in any way bothered or impaired by this absence.

The discovery is striking because most animals are bilaterally symmetrical, which means the left and right sides of the body roughly mirror each other. This bilateralism extends to many internal organs, although some systems, such as the human heart and liver, develop or are positioned asymmetrically.

“We’ve got two lungs, two kidneys, and females and males have paired gonads. Even our brain has two hemispheres,” said Kipling Will, assistant professor of insect biology at the University of California, Berkeley’s College of Natural Resources. “Evolution has predominantly favored bilateral symmetry in animals, so when we see that the rule is violated, as in the case with these beetles, it gets our attention.”

Will led a systematic survey of all major lineages of the beetle family Carabidae. The results of the survey will appear in the April print issue of the Journal of Morphology, but are available now online.

The researchers said that field observations such as this provide valuable clues to beetle biology and evolution.

The one-testis phenomenon, or monorchy, was first noted in beetles by French naturalist Leon Dufour in 1825. He found that Harpalini carabid beetles had a single testis, but he and other scientists considered the condition to be limited to this group. It would take another 180 years before researchers would conduct a more thorough survey, finding that two other major lineages also lack one testis.

The survey required detailed dissection and study of over 820 species, a representative sampling from the 37,000 species of carabid beetles estimated to exist. The researchers found 174 species, all members of the three lineages with only one testis. The researchers noted that except for this one anatomical distinction, the one-testicle beetles appear and behave no differently than their two-testicle counterparts.

“The beetles with one testis are mating normally and doing their beetle thing,” said James Liebherr, professor of entomology at Cornell University. “It strikes me that carabid beetles are pretty well known to scientists, yet the loss of an entire organ across three major lineages was not fully comprehended until this study.”

For reasons unknown, in almost all cases it is the left testis that has disappeared.

“You might say that these beetles lost all that was left, except for one small group that seems to have lost their right,” quipped Will, who is also associate director of UC Berkeley’s Essig Museum of Entomology.

While animals such as jellyfish and starfish are radially symmetrical, bilateral symmetry is, hands down, the dominant body shape in the animal world, thanks in part to the drive for forward motion.

That’s not to say there is no precedent for such deviations from bilateralism. One well-known example is the male fiddler crab, which has an outsized claw on one side that is used to attract female crabs and fend off male competitors.

Still, the researchers said the complete absence of an organ, or absence asymmetry, is rare. When it does occur, there is likely a good reason for the organ loss. Snakes, for example, have one lung that is significantly reduced to accommodate a relatively extreme body shape. Most birds have only one functioning ovary, which some biologists believe helps optimize their bodies for flight.

That raises the question of how and why some beetles evolved to have just one testis. The researchers ruled out obvious factors such as flight advantages or major changes in body form.

They did notice that the monorchid beetles’ accessory glands, which produce the bulk of the seminal fluid, were somewhat larger than normal. The researchers suggest that packing of the internal organs in the abdomen is a kind of competition for space that may lead to the loss of the functionally redundant testis.

“Male crickets will directly transfer fluid from their accessory glands to female crickets to provide nutrition to their eggs,” said Liebherr. “It may be that the male beetles are similarly providing other things than sperm to the females. But it’s a chicken and egg question. We don’t know what came first. Was the testis lost first, leaving more space for the accessory glands to grow? Or did the testis lose out to make way for a larger accessory gland? That’s a subject for further study.”

Whatever the ultimate cause, something drove the evolution of this absence asymmetry.

“We found monorchy in three distantly related groups of carabid beetles - Abacetini, Harpalini and Platynini - indicating that the loss of the testis occurred at least three separate times in the evolution of the beetles,” said Will. “It seems unlikely that it was completely random.”

Based on the geographic distributions of the beetle groups involved, Liebherr estimates that the origins of monorchy in the beetles occurred 90 to 100 million years ago during the Cretaceous period. “That era witnessed a dramatic increase in the diversity of organisms,” he said.

He added that these findings illustrate the value of basic natural history.

“So many of the scientific discoveries today seem to occur primarily on the molecular and genetic level, so findings such as this are remarkable,” said Liebherr. “A lot of the ideas that come to the lab bench start in the field. We still have much to discover by looking at whole organisms.”

Other co-authors are David Maddison at the University of Arizona and Jos?Gali醤 at the Departamento de Biolog韆 Animal Facultad de Veterinaria in Murcia, Spain.

This research was funded by the National Science Foundation.

Sarah Yang
scyang@berkeley.edu
510-643-7741
University of California - Berkeley
http://www.berkeley.edu

28
Jul

Biology / Biochemistry NewsUseful Links

Report highlights diseases from the environment

Main Category: Biology / Biochemistry News
Article Date: 05 Mar 2005 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article   icon newsletters

While many infectious diseases are caused by human-to-human transmission, others are caused by microorganisms that exist in the outside environment. Scientists from a variety of fields, including medicine and the environment, must work together to address the challenges posed by these environmental pathogens, according to a new report, From Outside to Inside: Environmental Microorganisms as Human Pathogens, released today by the American Academy of Microbiology.

“The key difference between environmental pathogens and other human pathogens is their ability to survive and thrive outside the host. Their widespread occurrence in the environment makes them difficult to monitor and control,” says Gerard Cangelosi of the Seattle Biomedical Research Institute at the University of Washington, one of the authors of the report. “The fields of medical and environmental microbiology need to be better integrated to stimulate the type of work that is required to combat environmental pathogens effectively, and the development and improvement of surveillance and reporting strategies should be a top priority.”

Environmental pathogens are defined as microorganisms that normally spend a substantial part of their lifecycle outside human hosts, but when introduced to humans cause disease with measurable frequency. They are carried in the water, soil, air, food and other parts of the environment and can affect almost every individual on the planet. Some examples of environmental pathogens include Legionella pneumophila (the cause of Legionnaires disease, often found in air conditioning systems), West Nile virus, and Cryptosporidium parvum (a parasite that can be found in food, drinking water and recreational waters).

In addition to better integration of medical and environmental research, the report recommends more effective monitoring of pathogens in the environment to allow researchers to better understand the incidence and persistence of pathogens in areas that are considered to be at risk for harboring these organisms. Multidisciplinary research must also be fostered to better predict how changes in the environment may affect the frequency of environmental diseases.

“These threats to human health can only be assessed in a comprehensive multidisciplinary context in which ecology, epidemiology, and emerging areas in environmental engineering and microbiology are integrated. This combined approach can yield immediate and long-term health benefits by mitigating established environmental risks, identifying risky situations for disease emerging and finding the causes of diseases of unknown etiology,” says Cangelosi.

The report is the result of a colloquium convened by the Academy in February 2004 to discuss environmental pathogens and the current state of research on these organisms. Scientists with expertise in infectious diseases, food microbiology, bacteriology, molecular biology, microbial ecology, pathogenic mycology and other areas in the microbiological sciences participated. Participants considered the knowledge gaps related to the incidence and epidemiology of environmental infectious diseases, dynamics of human pathogens in the environment, ways to alleviate environmental infectious diseases, research needs in the field and education and communication issues.

To read a fully copy of the report and recommendations please visit the Academy online at asm.org/Academy/index.asp?bid=2093 or contact the American Academy of Microbiology at colloquia@asmusa.org.

The American Academy for Microbiology is the honorific leadership group of the American Society for Microbiology. The mission of the Academy is to recognize scientific excellence, as well as foster knowledge and understanding in the microbiological sciences. For more information about the American Society for Microbiology, contact Barbara Hyde at 202-942-9206 or visit http://www.asm.org.

Contact: Angelo R. Bouselli
abouselli@asmusa.org
202-942-9292
American Society for Microbiology
http://www.asm.org

28
Jul

Biology / Biochemistry NewsUseful Links

$3.5 million for computer simulation of molecules

Main Category: Biology / Biochemistry News
Article Date: 03 Mar 2005 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article   icon newsletters

University of Utah chemist leads effort funded by Defense Department -

A University of Utah chemist will lead a new $3.5 million project to develop the next generation of computer simulation technology to study collections of molecules, including their chemical reactions.

About $1.7 million of the money - awarded by the Department of Defense’s Office of Naval Research - will go directly to the University of Utah, with the rest shared by three other participating research institutions, says Gregory A. Voth, professor of chemistry and director of the U’s Center for Biophysical Modeling and Simulation.

“This new project will be devoted to the development of cutting-edge computer simulation methods to describe chemical reactions,” says Voth, who directs the effort.

For the past 35 years, chemistry, biology and materials science have enjoyed extraordinary advances in quantum mechanics (the theory of the structure and behavior of atoms and molecules) and computer software that simulates that arrangement of atoms in molecules and the motion of molecules.

But researchers have yet to fully develop computer simulation software with the ability to accurately describe chemical reactivity in complicated molecular systems such as biological proteins and hydrogen fuel cells.

Voth was selected by the Office of Naval Research to lead a team of researchers to develop and add this capability to molecular simulation software. This advance, in turn, will greatly expand the application of molecular simulation techniques to many new scientific and engineering problems, such as the design of new sensors to detect chemical and biological warfare agents, and new fuels for rocket propulsion, he says.

“The Office of Naval Research is interested in using computer simulation in the design of many new materials for weapons systems, energy storage and delivery, and sensing and detection (for example, of chemical and biological warfare agents),” Voth says. “They see computer simulation as being a logical, efficient and cost-saving basic research approach to aid in these efforts.”

The research team also includes Thomas L. Cheatham, III, a University of Utah assistant professor of medicinal chemistry and pharmaceutics and pharmaceutical chemistry, as well as scientists from the University of California, Berkeley; the Scripps Research Institute in La Jolla, Calif.; and Wayne State University in Detroit.

University of Utah Public Relations
201 S Presidents Circle, Room 308
Salt Lake City, Utah 84112-9017
(801) 581-6773 fax: (801) 585-3350
http://www.utah.edu/unews

Contact: Gregory Voth
professor of chemistry
801-581-7272
voth@chem.utah.edu

Lee Siegel
science news specialist
801-581-8993 (office), 801-244-5399 (cell)
leesiegel@ucomm.utah.edu
University of Utah Public Relations
http://www.ucomm.utah.edu

28
Jul

Biology / Biochemistry NewsUseful Links

Medical Research Council Technology Announces Substantial Funding For Research Into Drug Targets, UK

Main Category: Biology / Biochemistry News
Article Date: 02 Mar 2005 - 10:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article   icon newsletters

Medical Research Council Technology (MRCT) - the body that commercialises some of the finest biomedical research in the world - today announced that it will co-fund work to develop new drug discovery techniques at the Medical Research Council’s Laboratory of Molecular Biology (LMB). MRCT will support the initiative from its Development Gap Fund, with additional funding provided by Pfizer, the world’s largest private biomedical research organisation.

The award will help the LMB develop techniques to elucidate the three dimensional structure of human G protein coupled receptors (GPCRs) - disease targets that have been key to research advances in the search for medicines to treat several conditions where there remains high medical need.

GPCRs are integral components of cell membranes and it is through these receptors that cells receive and respond to essential signals, including those from many drugs. GPCRs have been shown to be ideal targets for novel drug design. Many of the most-widely prescribed drugs in the world act on GPCRs, mitigating conditions as diverse as cancer, allergies, heart disease, migraine and stomach ulcers.

MRCT Chief Executive Officer Roberto Solario said:
“We are delighted that Pfizer has matched our funding for the MRC’s Laboratory Molecular Biology’s initiative. The science involved in this project is cutting-edge, and our hope is that it might lead to the elucidation of GPCR structures and thereby aid the identification of medicines to treat a broad range of diseases.”

For more information call the MRC press office on 0207 637 6011

Notes to editors

MRCT

MRC Technology (MRCT) is the technology transfer company of the Medical Research Council responsible for turning MRC scientific discoveries and inventions into technologies and products with healthcare benefits. The MRCT Development Gap Fund is a ?.5 million commercialisation programme, invested over three years, which is available to MRC scientists to help early-stage ideas and inventions progress towards use by patients and commercial success.

GPCRs

Understanding the three-dimensional structure of the drug target or GPCR can help in the development of new drugs. In spite of much work, the structure of only one GPCR has been solved to date; the photoreceptor in the eye (bovine rhodopsin). The structure of this molecule is very stable and it is, therefore, more robust. The aim of LMB’s research is to develop generic techniques to make any GPCR as stable as rhodopsin.

MEDICAL RESEARCH COUNCIL

28
Jul

Biology / Biochemistry NewsUseful Links

Unique Automated HPLC Method Development and Validation Software Speeds up Sample Throughput for Pharma and Biotech Applications

Main Category: Biology / Biochemistry News
Article Date: 01 Mar 2005 - 8:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article   icon newsletters

Varian, Inc today announced the availability of the new Fusion AE(TM) software companion plug-in application for its Galaxie(TM) Chromatography Data System (CDS) to enable automated high performance liquid chromatography (HPLC) method development and validation. Fusion AE integrates seamlessly with Varian’s Galaxie CDS software, offering users the ability to optimize methods based on simultaneously entered multiple variables on a variety of HPLC equipment from multiple vendors.

For pharmaceutical, biotechnology, and other industrial labs required to meet the requirements of regulatory authorities, such as the Federal Drug Administration (FDA) or Environmental Protection Agency (EPA), Fusion AE simplifies and streamlines the process, speeding up sample throughput by providing rapid optimization and validation of methods on a continuous basis.

In pharmaceutical research and development (R&D) laboratories, scientists can use Fusion AE’s method development/optimization option to rapidly and automatically optimize methods based on simultaneously entered multiple variables, such as mobile phase composition, flow rate, column packing functionality, injection volume, temperature, and pH, among others.

Competitive software packages are capable of studying only one or two variables simultaneously.

In addition, the new software’s phased approach to method validation lets scientists run quick checks to determine whether the method can be validated while in the development phase. Once optimized, the scientists then can run the full complement of required method validation experiments automatically.

This results in bench-time savings as well as higher sample throughput. Fusion AE(TM) meets the FDA’s stringent 21 CFR Part 11 regulatory requirements, and all method validation experiment designs, analysis, and reporting conform to FDA and ICH guidances.

In the same companies, quality control (QC) labs can use Fusion AE’s automated method validation component to revalidate analytical methods transferred from R&D, saving time and eliminating errors. Fusion AE has demonstrated a 60% to 85% reduction in cycle time (including data analysis and report generation) compared to current manual execution of validation standard operating procedures (SOPs).

Fusion AE is the latest add-on to enhance the functionality of Varian’s Galaxie CDS. At last year’s Pittcon, Varian introduced the Galaxie(TM) DataBase, which gave customers an option for either structured file or relational data storage and archiving. Combined with Fusion AE and Galaxie DataBase, Galaxie CDS is a complete software solution for compliant, networked environments.

Orders are currently being taken for the new Fusion AE, with shipments beginning in May 2005.

Varian, Inc. supplies a broad range of scientific instruments and consumable supplies for health science applications. Since 1999, the company has maintained a balanced approach to enhancing and expanding its products for life science and industrial customers.

For further product information on the Galaxie CDS and Fusion AE, please visit:
http://www.varianinc.com/products/chrom/cds/index.html .

Varian, Inc. is a major supplier of scientific instruments, vacuum technologies, and specialized contract electronics manufacturing services.

These businesses serve a broad range of life science and industrial customers worldwide. The company manufactures in 15 locations in North America, Europe, and the Pacific Rim, and employs some 4,600 people. Varian, Inc. had fiscal year 2004 sales of $916 million. Additional information about Varian, Inc. is available at http://www.varianinc.com.

For More Information, Contact:
Lauren Lum
Varian, Inc.
650-424-5286
lauren.lum@varianinc.com
Varian, Inc.
Pittcon Booth #4128
Galaxie(TM) Booth #2145

Varian, Inc.
http://www.varianinc.com

28
Jul

Biology / Biochemistry NewsUseful Links

UAB scientists discover the origin of a mysterious physical force

Main Category: Biology / Biochemistry News
Article Date: 01 Mar 2005 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article   icon newsletters

Discovery will lead to improvements in the chemical, pharmaceutical and food industry -

Ever since the 1970s, scientists have been trying to establish the cause of a repulsive force occurring between different electrostatically charged molecules, such as DNA and other biomolecules, when they are very close to each other in aqueous media. This force became know as hydration force.

Jordi Faraudo, a researcher for the Department of Physics at the Universitat Aut騨oma de Barcelona, and Fernando Bresme of the Department of Chemistry at Imperial College London have studied this mysterious force in detail and have discovered where its origins lie.

In the same way that a flag flutters in the direction the wind is blowing, at a microscopic level water molecules are gently attracted towards the direction in which an electric field is pointing. However, when the water is in contact with surfaces that create small electric fields, such as chemical compounds like those found in many detergents, this is no longer the case: the water molecules have a remarkable capacity to organise themselves into complex structures that are strongly orientated in such a way as to cancel out the electric field, and on some occasions, to reverse it. This abnormal behaviour was discovered by the same researchers and published in Physical Review Letters in April 2004.

The scientists have now discovered that this strange property is responsible for the hydration force that acts when water is surrounded by certain types of electrostatically charged molecules, such as DNA and some biological compounds, and when thin films form in detergents. The discovery has been published in today’s edition of Physical Review Letters.

Water is the solvent in which most physical, chemical and biological processes take place. Therefore, it is essential to understand the nature of interactions between molecules dissolved in water in order to understand many of these processes. Two of the most important of these processes are the adherence of substances to cell membranes and the withdrawal of proteins. Both of these are fundamental in biomedical research, since a substantial part of the process of designing new drugs is based on understanding how substances penetrate cell membranes to enter cells. These drugs are often proteins designed to prevent or strengthen the action of other substances. In these cases, accurately identifying the protein folding is essential, since the form these proteins take on when they fold influences how effectively they are able to act.

Fully understanding the properties of this force that occurs when molecules surrounded by water adhere to each other is also useful in the chemical industry, particularly when involving mechanisms in which colloidal suspensions must be stabilised, such as the mechanisms used to produce paints, cosmetics and food products such as yoghurt and mayonnaise.

This press release is also available in Spanish.

Contact: Octavi L髉ez Coronado
octavi.lopez@uab.es
34-93-581-3301
Universitat Autonoma de Barcelona
http://www.uab.es

27
Jul

Biology / Biochemistry NewsUseful Links

Toray Industries Develops Innovative Plastic and Hypersensitive Chip for Protein Analysis

Main Category: Biology / Biochemistry News
Article Date: 26 Feb 2005 - 18:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article   icon newsletters

Tokyo (JCNN) - Toray Indsutries (TSE: 3402) has announced that it has prototyped a plastic chip designed for protein analysis. This half-card sized chip can detect a minute amount of disease-related proteins with 100 times the high sensitivity of the existing chip.

Using a minute amount of sample, the prototype chip conducts essential analytical procedures such as purification, separation (electrophoresis) and detection.

Toray expects that the latest breakthrough technology will pave the way for the advancement of biotechnologies including tailor-made medicine, proteome research and safety tests in the food and environmental industries.

View Toray Industries, Inc. company profile here

Copyright ?2001-2004 JCNN. All rights reserved. A division of Japan Corporate News Network KK.

27
Jul

Biology / Biochemistry NewsUseful Links

GSI Creos Develops Innovative Cell Culture Incubator Using Cup-stacked Carbon Nanotubes

Main Category: Biology / Biochemistry News
Article Date: 26 Feb 2005 - 18:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article   icon newsletters

Tokyo (JCNN) - GSI Creos (TSE: 8101) has announced that it has prototyped Carbere, a new cell culture incubator, using its proprietary cup-stacked-type carbon nanotubes (CSCNT). The new incubator, which takes advantages of the CSCNT’s surface activity, increases the yields of antibodies and proteins as well as proliferates cells that are difficult to be incubated.

The prototype is exhibited at nano tech 2005 held at the Tokyo Big Sight from February 23. Starting this fall, the company will provide Carbere prototype samples to laboratories in the fields of pharmaceutical, medical material and food.

View GSI Creos Corporation company profile here

Copyright ?2001-2004 JCNN. All rights reserved. A division of Japan Corporate News Network KK.

27
Jul

Biology / Biochemistry NewsUseful Links

NTT Prototypes Technology to Use Human Body As Digital Transmission Path

Main Category: Biology / Biochemistry News
Article Date: 26 Feb 2005 - 18:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article   icon newsletters

Tokyo (JCNN) - NTT (TSE: 9432) has developed an innovative human area networking technology called RedTacton (red implies a warm color; tacton is coined with “touch” and “action”) that turns the surface of a human body into a data transmission path. RedTacton uses weak electric fields on the surface of the body as a transmission medium to enable data speeds of up to 10Mbps between any two points on the body.

The company has prototyped a small PCMCIA card-sized RedTacton transceiver that uses a novel electro-optic sensor, which bounces a laser beam off of an electro-optic crystal and measures the reflected beam. The card transceiver induces extremely weak electric fields on the body surface, which pass through the body to the receiver and causes changes in the optical properties of an electro-optic crystal. The extent to which the changes are made is detected by laser light, which is then converted to an electrical signal by a detector circuit.

RedTacton is characterized by three functional features: A communications path can be created with a simple touch, automatically initiating the flow of data between a body-centric electronic device and a computer that is embedded in the environment; the electro-optic sensor enables two-way communications at up to 10Mbps between any two points on the body; RedTacton can use a wide range of materials as a transmission medium, as long as it is conductive and dielectric, which includes water and other liquids, various metals, certain plastics, and glass.

NTT mentions possible applications including personalized one-to-one services, the intuitive operation of personal information devices, user-registration-free device personalization, and security applications.

View NTT company profile here

Copyright ?2001-2004 JCNN. All rights reserved. A division of Japan Corporate News Network KK.

27
Jul

Biology / Biochemistry NewsUseful Links

New binding target for oncogenic viral protein

Main Category: Biology / Biochemistry News
Article Date: 26 Feb 2005 - 17:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article   icon newsletters

The DNA tumor virus simian virus 40 produces the Large T antigen which inactivates two of the cell’s most important cancer-preventing proteins, p53 and pRb. In a study published in the Journal of Biological Chemistry, researchers at the Fred Hutchinson Cancer Research Center report the discovery of an additional target for T antigen–a protein called Fbw7.

The Fbw7 gene is located in a chromosomal region that is deleted in up to 30% of human tumors. “Fbw7 is itself an important tumor suppressor which makes it an attractive choice for inactivation by Large T,” explained Dr. Markus Welcker, the study’s first author.

The research appears as the “Paper of the Week” in the March 4 issue of the Journal of Biological Chemistry, an American Society for Biochemistry and Molecular Biology journal.

DNA tumor viruses proliferate by hijacking their host cell’s DNA replication machinery. In order to do this, they have evolved mechanisms to override normal cellular replication controls. Simian virus 40 (SV40) accomplishes this task by producing the highly oncogenic large T antigen. This protein corrupts the cellular checkpoint mechanisms that guard cell division and the transcription, replication and repair of DNA. T antigen also inactivates some of the most important proteins that protect cells against malignant transformation, including tumor suppressor proteins p53 and pRb.

In the Journal of Biological Chemistry paper, Dr. Welcker and Dr. Bruce Clurman report that T antigen also binds to another tumor suppressor, Fbw7. This protein is part of a ubiquitin ligase complex that adds ubiquitin to proteins to mark them for destruction by the cell. Fbw7 recognizes a destruction signal on certain proteins that need to be degraded and brings them in close proximity to the enzymes that attach ubiquitin. The proteins recognized by Fbw7 play key roles in cell division, cell growth, differentiation, and cell death.

“These proteins are also some of the most broadly acting cellular oncogenes, and include cyclin E, c-Myc, Notch, and c-Jun,” noted Dr. Clurman. “When Fbw7 is mutated in cancers, deregulation of these oncogenic Fbw7 targets is thought to contribute to cancer. SV40 T antigen contains a motif that mimics the destruction signal found in these proteins.” However, unlike the other substrates recognized by Fbw7, T antigen is not destroyed by the cell.

Drs. Clurman and Welcker suspect that by acting as a decoy and binding to Fbw7, T antigen protects cellular Fbw7 targets that facilitate viral replication and tumorigenesis.

“I think this work underlines the importance of Fbw7 as an emerging tumor suppressor and the consequences of its loss in tumors,” Dr. Welcker emphasized.

“The study of DNA tumors viruses has been an extremely important tool in understanding the cellular pathways that regulate cell division and are disrupted in cancer. Understanding the mechanisms through which these viruses interact with the cellular machinery that regulates cell division may lead to new insights into the pathways that cause cancer. This is an important step to designing new cancer treatment strategies that target these pathways,” concluded Dr. Clurman.

———————–

The Journal of Biological Chemistry’s Papers of the Week is an online feature which highlights the top one percent of papers received by the journal. Brief summaries of the papers and explanations of why they were selected for this honor can be accessed directly from the home page of the Journal of Biological Chemistry online at www.jbc.org.

Contact: Nicole Kresge
nkresge@asbmb.org
American Society for Biochemistry and Molecular Biology